These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 4849495)
1. [Problems posed by formulation of dry forms with delayed action administered orally]. Delporte JP Farmaco Prat; 1974 Aug; 29(8):407-32. PubMed ID: 4849495 [No Abstract] [Full Text] [Related]
2. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms]. Hänselmann B; Voigt R Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108 [No Abstract] [Full Text] [Related]
3. [Development of an oral nitroglycerin proxyphyllin retard compound]. Ritschel WA; Clotten R Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053 [No Abstract] [Full Text] [Related]
4. [Effect of the production process on the quality of drugs]. Murav'ev IO Farm Zh; 1976; (2):20-7. PubMed ID: 1269692 [No Abstract] [Full Text] [Related]
5. Assessment of the feasibility of oral controlled release in an exploratory development setting. Thombre AG Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208 [TBL] [Abstract][Full Text] [Related]
6. The in vitro development of extended-release solid oral dosage forms. Leeson LJ; Adair D; Clevenger J; Chiang N J Pharmacokinet Biopharm; 1985 Oct; 13(5):493-514. PubMed ID: 3834065 [TBL] [Abstract][Full Text] [Related]
7. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771 [TBL] [Abstract][Full Text] [Related]
9. Drug formulation and biologic availability. Poole JW Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883 [No Abstract] [Full Text] [Related]
10. [Evaluation of the physiological availability of drug substances in capsules]. Mikhaĭlova GS Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209 [No Abstract] [Full Text] [Related]
11. [Biopharmaceutical aspects of pharmaceutical technology]. Thoma K Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982 [No Abstract] [Full Text] [Related]
12. The physicochemical and pharmacokinetic bases for the biopharmaceutical evaluation of drug biological availability in pharmaceutical formulations. Garrett ER Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():1-29. PubMed ID: 5316401 [No Abstract] [Full Text] [Related]
13. Bioavailability studies of nitrates in the dog. Hastings SG Arch Int Pharmacodyn Ther; 1973 May; 203(1):117-22. PubMed ID: 4199057 [No Abstract] [Full Text] [Related]
14. Effect of sampling procedures of release testing on drug release and scale-up production feasibility of multiple-unit dextromethorphan resinate tablets: a technical note. Pongjanyakul T AAPS PharmSciTech; 2007 Dec; 8(4):E117. PubMed ID: 18181538 [TBL] [Abstract][Full Text] [Related]
15. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances]. Hüttenrauch R; Schmeiss U Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778 [No Abstract] [Full Text] [Related]
16. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis. Chuong MC; Christensen JM; Ayres JW Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272 [TBL] [Abstract][Full Text] [Related]
17. [Principles of retardation]. Hüttenrauch R Pharmazie; 1975 Jan; 30(1):3-16. PubMed ID: 1094473 [No Abstract] [Full Text] [Related]
18. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid. Zhao L; Ding J; He P; Xiao C; Tang Z; Zhuang X; Chen X J Control Release; 2011 Nov; 152 Suppl 1():e184-6. PubMed ID: 22195840 [No Abstract] [Full Text] [Related]
19. Comparative activity of drugs: a new role for USP. Robinson JR J Parenter Sci Technol; 1988; 42(2):39. PubMed ID: 3385540 [No Abstract] [Full Text] [Related]